• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Healthcare Capital Corp.

    2/2/22 5:29:50 PM ET
    $HCCC
    Get the next $HCCC alert in real time by email
    SC 13G 1 cohenco-hccc012522.htm



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. )*



    Healthcare Capital Corp.

    (Name of Issuer)

     

    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    42228C101

    (CUSIP Number)

     

     

    January 25, 2022
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    o Rule 13d-1(b)

    x Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 2 of 13 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Vellar Opportunities Fund Master, Ltd.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,542,264
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,542,264
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,542,264
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.6%
    12
    TYPE OF REPORTING PERSON
     
    CO

     


     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 3 of 13 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Cohen & Company Financial Management, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,542,264
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,542,264
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,542,264
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.6%
    12
    TYPE OF REPORTING PERSON
     
    IA, OO

     


     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 4 of 13 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Dekania Investors, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,542,264
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,542,264
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,542,264
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.6%
    12
    TYPE OF REPORTING PERSON
     
    OO, HC
     


     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 5 of 13 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Cohen & Company LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,542,264
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,542,264
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,542,264
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.6%
    12
    TYPE OF REPORTING PERSON
     
    OO, HC

     

     


     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 6 of 13 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Cohen & Company Inc.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,542,264
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,542,264
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,542,264
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.6%
    12
    TYPE OF REPORTING PERSON
     
    CO, HC
     


     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 7 of 13 Pages

     

             
    1
    NAME OF REPORTING PERSONS
     
    Daniel G. Cohen
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    1,542,264
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    1,542,264
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,542,264
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    5.6%
    12
    TYPE OF REPORTING PERSON
     
    IN, HC
     


     

     

    CUSIP No. 42228C101
     SCHEDULE 13G
    Page 8 of 13 Pages

     

    Item 1.(a) Name of Issuer

    Healthcare Capital Corp.

    Item 1.(b) Address of Issuer’s Principal Executive Offices

    301 North Market Street, Suite 1414

    Wilmington, DE 19801

    Item 2.(a) Name of Persons Filing:

    Vellar Opportunities Fund Master, Ltd.

    Cohen & Company Financial Management, LLC

    Dekania Investors, LLC

    Cohen & Company LLC

    Cohen & Company Inc.

    Daniel G. Cohen

      

    Item 2.(b) Names of Person Filing, Address of Principal Business Office, Citizenship:

    Vellar Opportunities Fund Offshore, Ltd.

    c/o Mourant Governance Services (Cayman) Limited 94

    Solaris Avenue, Camana Bay

    PO Box 1348 Grand Cayman KY1-1108

    Cayman Islands

     

    Cohen & Company Financial Management, LLC

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

     

    Dekania Investors, LLC

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

     

    Cohen & Company LLC

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

     

    Cohen & Company Inc.

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

     

    Daniel Cohen

    c/o Cohen & Company Inc.

    3 Columbus Circle, Suite 2400

    New York, New York 10019

    United States

      

    Item 2.(c) Citizenship:

     

    Vellar Opportunities Fund Master, Ltd. – Cayman Islands

    Cohen & Company Financial Management, LLC – Delaware, United States

    Dekania Investors, LLC – Delaware, United States

    Cohen & Company LLC – Delaware, United States

    Cohen & Company Inc. – Delaware, United States

    Daniel G. Cohen – United States

      

    Item 2.(d) Title of Class of Securities

    Class A Common Stock, par value $0.0001 per share (the “Common Stock”)

     

    Item 2.(e) CUSIP No.:

    42228C101

     

    CUSIP No.  42228C101
     SCHEDULE 13G
    Page 9 of 13 Pages

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
      (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
      (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
           

     

    CUSIP No. 42228C101
     SCHEDULE 13G
    Page 10 of 13 Pages

     

     

    Item 4. Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    Vellar Opportunities Fund Master, Ltd.

    (a) Amount beneficially owned: 1,542,264

    (b) Percent of class: 5.6%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,542,264

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,542,264

     

    Cohen & Company Financial Management, LLC

    (a) Amount beneficially owned: 1,542,264

    (b) Percent of class: 5.6%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,542,264

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,542,264

     

    Cohen & Company Inc.

    (a) Amount beneficially owned: 1,542,264

    (b) Percent of class: 5.6%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,542,264

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,542,264

     

    Dekania Investors, LLC.

    (a) Amount beneficially owned: 1,542,264

    (b) Percent of class: 5.6%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,542,264

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,542,264

     

    Cohen & Company, LLC

    (a) Amount beneficially owned: 1,542,264

    (b) Percent of class: 5.6%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,542,264

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,542,264

     

    Daniel G. Cohen:

    (a) Amount beneficially owned: 1,542,264

    (b) Percent of class: 5.6%

    (c) Number of shares to which the person has:

    (i) Sole power to vote or to direct the vote:

    (ii) Shared power to vote or to direct the vote: 1,542,264

    (iii) Sole power to dispose or direct the disposition:

    (iv) Shared power to dispose or to direct the disposition: 1,542,264

     

    Item 5. Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

    Not Applicable.

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Please see Exhibit II attached hereto.

    Item 8. Identification and Classification of Members of the Group

    Not Applicable.

    Item 9. Notice of Dissolution of Group 

    Not Applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     
    CUSIP No. 42228C101
     SCHEDULE 13G
    Page 11 of 13 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 2, 2022

     

     

     

     

    Vellar Opportunities Fund Master, Ltd.

           
      By:  /s/ Solomon I. Cohen
        Solomon I. Cohen, Director
           
     

    Cohen & Company Financial Management, LLC

    By: Cohen & Company Inc.

           
      By:  /s/ Daniel G. Cohen
        Daniel G. Cohen, Chairman of the Board of Directors
           
     

    Dekania Investors, LLC

           
      By:  /s/ Joseph Pooler
        Joseph Pooler, Chief Financial Officer
           
     

    Cohen & Company LLC

           
      By:  /s/ Joseph Pooler
        Joseph Pooler, Chief Financial Officer
           
     

    Cohen & Company Inc.

           
      By:  /s/ Daniel G. Cohen
        Daniel G. Cohen, Chairman of the Board of Directors
           
     

           
      By:  /s/ Daniel G. Cohen
       
           
           

     

     
    CUSIP No. 42228C101
     SCHEDULE 13G
    Page 12 of 13 Pages

     

    Exhibit I

     

    JOINT FILING STATEMENT

     

    PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint Acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Dated: February 2, 2022

     

     

    Vellar Opportunities Fund Master, Ltd.

           
      By:  /s/ Solomon I. Cohen
        Solomon I. Cohen, Director
           
     

    Cohen & Company Financial Management, LLC

    By: Cohen & Company Inc.

           
      By:  /s/ Daniel G. Cohen
        Daniel G. Cohen, Chairman of the Board of Directors
           
     

    Dekania Investors, LLC

           
      By:  /s/ Joseph Pooler
        Joseph Pooler, Chief Financial Officer
           
     

    Cohen & Company LLC

           
      By:  /s/ Joseph Pooler
        Joseph Pooler, Chief Financial Officer
           
     

    Cohen & Company Inc.

           
      By:  /s/ Daniel G. Cohen
        Daniel G. Cohen, Chairman of the Board of Directors
           
     

           
      By:  /s/ Daniel G. Cohen
     
     
     
    CUSIP No. 42228C101
     SCHEDULE 13G
    Page 13 of 13 Pages

     

    Exhibit II

     

    Cohen & Company Financial Management, LLC and Cohen & Company Inc. are the relevant entities for which Mr. Cohen may be considered a control person.

    Get the next $HCCC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCCC

    DatePrice TargetRatingAnalyst
    1/24/2022$18.00Buy
    Ladenburg Thalmann
    More analyst ratings

    $HCCC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Milch David Mark converted options into 1,923,925 shares and disposed of 1,923,925 shares

    4 - Healthcare Capital Corp/DE (0001822935) (Issuer)

    3/9/22 9:30:25 PM ET
    $HCCC

    SEC Form 4: Doyle Michael was granted 2,500 units of Common Stock

    4 - VISION HYDROGEN Corp (0001676580) (Issuer)

    5/14/21 1:08:25 PM ET
    $HCCC

    SEC Form 4: BENTON CHARLES F was granted 2,500 units of Common Stock

    4 - VISION HYDROGEN Corp (0001676580) (Issuer)

    5/14/21 1:06:11 PM ET
    $HCCC

    $HCCC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

    JERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. (NASDAQ:HCCC) ("HCCC"), a special purpose acquisition company, announced today the successful closing of the previously announced business combination (the "Business Combination"). The combined company will continue to be led by Alpha Tau's existing management team. Alpha Tau's ordinary shares and warrants are expected to begin trading on Tuesday, March 8, 2022, on Nasdaq under the ticker symbols "DRTS" and "DRTSW," respectively. The transaction, and the various proposals giving effect ther

    3/7/22 8:32:00 AM ET
    $HCCC

    Healthcare Capital Corp. and Alpha Tau Medical Ltd. Announce Stockholder Approval of the Business Combination

    NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) --  Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") and Alpha Tau Medical Ltd. ("Alpha Tau"), an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors, today announced that in its special meeting held on February 18, 2022, HCCC's stockholders voted to approve the previously announced proposed business combination (the "Business Combination") of HCCC and Alpha Tau. Approximately 94.57% of the votes cast at the meeting, representing approximately 65.64% of HCCC's outstanding shares as of the record date, voted

    2/22/22 7:30:00 AM ET
    $HCCC

    Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders

    NEW YORK, NY, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") today announced that on February 18, 2022, it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the "Special Meeting"). The Special Meeting has been adjourned until February 18, 2022 at 4:00p.m. Eastern Time (the "Adjournment"). The Special Meeting is being held to approve the business combination (the "Business Combination") with Alpha Tau Medical Ltd. ("Alpha Tau") and related proposals, as described in HCCC's definitive proxy statement filed with the Securities and Exchange Commission ("SEC") on January 14, 2022. The

    2/18/22 11:38:11 AM ET
    $HCCC

    $HCCC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ladenburg Thalmann initiated coverage on Healthcare Capital with a new price target

    Ladenburg Thalmann initiated coverage of Healthcare Capital with a rating of Buy and set a new price target of $18.00

    1/24/22 7:16:23 AM ET
    $HCCC

    $HCCC
    SEC Filings

    View All

    SEC Form 25-NSE filed by Healthcare Capital Corp.

    25-NSE - Healthcare Capital Corp/DE (0001822935) (Subject)

    3/7/22 4:22:12 PM ET
    $HCCC

    Healthcare Capital Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Healthcare Capital Corp/DE (0001822935) (Filer)

    2/22/22 4:05:34 PM ET
    $HCCC

    SEC Form 425 filed by Healthcare Capital Corp.

    425 - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/18/22 1:10:14 PM ET
    $HCCC

    $HCCC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Healthcare Capital Corp. (Amendment)

    SC 13G/A - Healthcare Capital Corp/DE (0001822935) (Subject)

    3/9/22 11:16:23 AM ET
    $HCCC

    SEC Form SC 13G filed by Healthcare Capital Corp.

    SC 13G - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/18/22 4:13:27 PM ET
    $HCCC

    SEC Form SC 13G filed by Healthcare Capital Corp.

    SC 13G - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/14/22 4:01:26 PM ET
    $HCCC